Bone marrow-derived mesenchymal stem cells for treatment of chronic graft vs. host disease

The aim of this study is to assess the safety and efficacy of bone marrow-derived mesenchymal stem cells (BM-MSCs) for treatment of extensive chronic graft vs. host disease (GvHD), associated with skin and/or liver damage in patients who underwent a transplantation with hematopoietic stem cells (HSCs).